Seeing Is Believing
Currently out of the existing stock ratings of Stephanie Davis, 132 are a BUY (58.93%), 72 are a HOLD (32.14%), 20 are a SELL (8.93%).
Analyst Stephanie Davis, currently employed at BARCLAYS, carries an average stock price target met ratio of 79.25% that have a potential upside of 20.13% achieved within 186 days.
Stephanie Davis’s has documented 432 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on DGX, Quest Diagnostics at 11-Feb-2026.
Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Jan-2025
$16
1 years 1 months 16 days ago
(08-Jan-2025)
2/3 (66.67%)
$1.01 (6.74%)
79
Hold Since 08-Jan-2025
$5.75
1 years 1 months 16 days ago
(08-Jan-2025)
4/12 (33.33%)
$1.71 (42.33%)
54
Buy Since 07-Sep-2022
1 years 1 months 16 days ago
(08-Jan-2025)
5/14 (35.71%)
$5.42 (151.40%)
88
Hold Since 08-Jan-2025
$7.03
$0.01 (0.14%)
$8
1 years 1 months 16 days ago
(08-Jan-2025)
5/11 (45.45%)
$0.17 (2.48%)
112
$5
$-2.02 (-28.77%)
$6
1 years 2 months 7 days ago
(17-Dec-2024)
10/13 (76.92%)
$1.6 (47.06%)
44
Which stock is Stephanie Davis is most bullish on?
What Year was the first public recommendation made by Stephanie Davis?